These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7405235)

  • 1. [Elimination of practolol in uremia].
    Wierzchowiecki M; Michałowska D; Tomaszkiewicz T; Maćkowiak M; Ochotny R
    Wiad Lek; 1980 May; 33(9):677-81. PubMed ID: 7405235
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of practolol in renal failure.
    Bodem G; Grieser H; Eichelbaum M; Gugler R
    Eur J Clin Pharmacol; 1974 Jul; 7(4):249-52. PubMed ID: 4853603
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of practolol in the rabbit with experimental glomerulonephritis.
    Harvengt C; Desager JP; Vanderbist M
    Pharmacology; 1975; 13(6):533-8. PubMed ID: 1221435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the serum half life of lividomycin in uraemic patients.
    Humbert G; Fillastre JP; Daufresne MF; Dubois D; Leroy A
    Curr Ther Res Clin Exp; 1974 Mar; 16(3):232-8. PubMed ID: 4206730
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: An investigation of the rat in situ absorption model using practolol and propranolol.
    Taylor DC; Grundy RU
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():65P. PubMed ID: 2741
    [No Abstract]   [Full Text] [Related]  

  • 6. Biliary excretion and enterohepatic recirculation of practolol in man.
    Carruthers SG; Kelly JG; Johnson GW; McDevitt DG
    Ir J Med Sci; 1976 Jun; 145(6):187-94. PubMed ID: 939682
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs.
    Bell JM; Russell CJ; Nelson JK; Kelly JG; McDevitt DG
    Br J Clin Pharmacol; 1977 Feb; 4(1):79-82. PubMed ID: 14661
    [No Abstract]   [Full Text] [Related]  

  • 8. Practolol metabolism. II. Metabolism in human subjects.
    Reeves PR; Case DE; Jepson HT; McCormick DJ; Nicholls JT; Felix RH; Holt PJ; Zacharias FJ; Fluke RW
    J Pharmacol Exp Ther; 1978 May; 205(2):489-98. PubMed ID: 641844
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of uremia on the accessibility of phosphomycin into interstitial tissue fluid.
    Fernandez Lastra C; Mariño EL; Dominguez-Gil A; Tabernero JM; Gonzalez Lopez A; Yuste Chaves M
    Eur J Clin Pharmacol; 1983; 25(3):333-8. PubMed ID: 6628521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The elimination of practolol by two human subjects.
    Dring LG; Gorchein A; Mahgoub AA; Smith RL
    Br J Clin Pharmacol; 1978 Mar; 5(3):262-5. PubMed ID: 148896
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of duration of infusion on elimination rate of alfentanil].
    Castor G; Altmayer P; Venitz J
    Anaesthesiol Reanim; 1995; 20(4):97-100. PubMed ID: 7575958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma kinetics of 125I-labelled amyloid P component in beta 2M amyloidosis: a possible approach to quantitate disease activity.
    Zingraff J; Caillat-Vigneron N; Ureña P; Gagné ER; Bererhi L; Moretti JL; Bardin T; Drüeke TB
    Nephrol Dial Transplant; 1995; 10(2):223-9. PubMed ID: 7753457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sufentanil pharmacokinetics in young adult and elderly surgical patients.
    Helmers JH; van Leeuwen L; Zuurmond WW
    Eur J Anaesthesiol; 1994 May; 11(3):181-5. PubMed ID: 8050423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term drugs on alfentanil clearance in patients undergoing renal transplantation.
    Koehntop DE; Noormohamed SE; Fletcher CV
    Pharmacotherapy; 1994; 14(5):592-9. PubMed ID: 7997393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Elimination of drugs. Elimination half-life of a drug].
    Della Negra M; Woronoff-Lemsi MC
    Soins; 1998; (627):57-8. PubMed ID: 9783022
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacokinetics study of intraperitoneal cisplatin in ovarian carcinoma].
    Han GR; Cai GF
    Zhonghua Fu Chan Ke Za Zhi; 1993 Apr; 28(4):224-6, 254. PubMed ID: 8404307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin and oxociprofloxacin pharmacokinetics in patients on haemodialysis.
    Drinovec J; Mrhar A; Bren A; Primozic S; Karba R; Varl J; Kozjek F
    J Chemother; 1989 Jul; 1(4 Suppl):565-6. PubMed ID: 16312534
    [No Abstract]   [Full Text] [Related]  

  • 18. Altered serum clearance of intravenously administered clindamycin phosphate in patients with uremia.
    Joshi AM; Stein RM
    J Clin Pharmacol; 1974; 14(2):140-4. PubMed ID: 4591489
    [No Abstract]   [Full Text] [Related]  

  • 19. Gentamicin pharmacokinetics in adults with bacterial endocarditis.
    Rosell-Rovira ML; Pou-Clavé L; García-Beltran L; Pascual-Mostaza C
    Am J Hosp Pharm; 1994 Jun; 51(11):1429-32. PubMed ID: 7942877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ketoconazole on cyclosporine metabolism in renal allograft recipients.
    Sorenson AL; Lovdahl M; Hewitt JM; Granger DK; Almond PS; Russlie HQ; Barber D; Matas AJ; Canafax DM
    Transplant Proc; 1994 Oct; 26(5):2822. PubMed ID: 7940888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.